Linchpin Biosciences Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.50 M
- Company Age 8 Year, 11 Days
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.00 M
- Revenue Growth 15.57%
- Profit Growth 240.03%
- Ebitda -11.30%
- Net Worth 28.28%
- Total Assets -2.49%
About Linchpin Biosciences
Linchpin Biosciences Private Limited (LBPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 January 2017 (Eight years 11 days old ). Its registered office is in Raigarh, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company has closed loans amounting to ₹4.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Dinesh Shinde, Ashok Ghodke, Babita Ghodke, and Two other members serve as directors at the Company.
Company Details
-
Location
Raigarh, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33309MH2017PTC289963
-
Company No.
289963
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Jan 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Linchpin Biosciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Ghodke
|
Managing Director | 27-Jan-2017 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Dinesh Shinde
|
Director | 27-Jan-2017 | Current |
|
Babita Ghodke
|
Director | 09-Sep-2017 | Current |
|
Laxman Kokate
|
Director | 02-Jun-2023 | Current |
|
Jayalaxmi Shinde
|
Director | 27-Jan-2017 | Current |
Financial Performance of Linchpin Biosciences.
Linchpin Biosciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 15.57% increase. The company also saw a substantial improvement in profitability, with a 240.03% increase in profit. The company's net worth Soared by an impressive increase of 28.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Linchpin Biosciences?
In 2019, Linchpin Biosciences had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹4.00 M
Charges Breakdown by Lending Institutions
- Bank Of India : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 May 2017 | Bank Of India | ₹4.00 M | Satisfied |
How Many Employees Work at Linchpin Biosciences?
Unlock and access historical data on people associated with Linchpin Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Linchpin Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Linchpin Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
